serine has been researched along with lrrk2-in1 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alessi, DR; Davies, P; Deng, X; Dzamko, N; Gray, NS; Lee, JD; Liu, Q; Nomanbhoy, TK; Patricelli, MP; Prescott, A; Yang, Q | 1 |
Bolognesi, P; Frassineti, M; Longo, F; Mercatelli, D; Morari, M; PisanĂ², CA; Shimshek, DR | 1 |
2 other study(ies) available for serine and lrrk2-in1
Article | Year |
---|---|
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2.
Topics: Benzodiazepinones; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; HEK293 Cells; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Mutation; Parkinson Disease; Phosphorylation; Protein Serine-Threonine Kinases; Pyrimidines; Serine | 2011 |
Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes.
Topics: Aminopyridines; Animals; Benzamides; Benzodiazepinones; Corpus Striatum; Dopamine; Exocytosis; Gene Knock-In Techniques; Glutamic Acid; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Mice; Phosphorylation; Pyrimidines; Serine; Synaptosomes; Visual Cortex | 2019 |